We demonstrate in this paper that the G1 phase speci®c cell cycle regulator cyclin E is able to provoke focus formation when cotransfected with activated Ha-ras into primary rat embryo ®broblasts (REFs). Cyclin E/Ha-ras transformed cells are highly tumorigenic in synergeneic rats, are able to form colonies in soft agar and show protection towards apoptosis upon serum starvation or DNA damage compared to cells transformed by the combination of Myc, cyclin D1 or SV40 large T-antigen and Ha-ras. Lines that were established after cyclin E/ Ha-ras or cyclin D1/Ha-ras transformation contain a large percentage of polyploid cells. This was not observed in cells transformed with other oncoproteins and Ha-ras pointing to an involvement of D-and E type cyclins in genomic instability. The cyclin dependent kinase inhibitors p21 and p27 but also p16 completely abrogate focus formation by cyclin E and Ha-ras suggesting that the oncogenic activity of cyclin E still requires functional G1 speci®c cyclin/CDK complexes. Moreover, inhibition of Myc function also blocks the oncogenic activity of cyclin E indicating a requirement of Myc for cyclin E function. The ®ndings presented here demonstrate that cyclin E can act as an oncoprotein with a potential involvement in genomic instability and the prevention of cell death. Our data also present more evidence for a strict functional interdependency between G1 cyclin/CDK complexes and c-Myc.
Introduction
Progression of cells through the G1 phase of the cellular division cycle is mainly governed by the activity of two cyclin/CDK complexes. In early G1, D-type cyclin/CDK complexes are induced and overexpression of both D-and E-type cyclins shortens progression through G1 in a number of dierent mammalian cells tested (Jiang et al., 1993; Kato and Sherr, 1993; Resnitzky et al., 1994) . In contrast to Dtype cyclins whose function is required in mid-to late G1, the expression of cyclin E reaches its maximal level at the G1/S border. Cyclin E is associated with CDK2 and this complex appears to be necessary for the onset of DNA replication. In this regard, cyclin E is thought to function downstream of cyclin D1 and is rate limiting for G1/S transition (Ko et al., 1992; Dulic et al., 1992; Pagano et al., 1993; Ohtsubo et al., 1995) . A considerable number of experimental data suggests that the tumour suppressor protein Rb is one of the substrates of the cyclin D1/CDK4 and the cyclin E/ CDK2 kinase (Dowdy et al., 1993; Ewen et al., 1993; Hinds et al., 1994; Kato and Sherr, 1993; Matsushime et al., 1994; Meyerson and Harlow, 1994; Hu et al., 1992; Sherr, 1995) . According to this hypothesis, Rb is hyperphosphorylated by either D-type or E-type cyclin/ CDK kinases and allows progression to the late G1 phase by releasing transcription factors of the E2F family that prepare the entry into S-phase. A number of other`pocket' proteins that are structurally related to Rb also appear to be substrates for cyclin/CDK complexes. Among them are p107 and p130 (for review see Lam and LaThangue, 1994; Sherr, 1995) . More recently, it has been shown that p107 is phosphorylated by cyclin D/CDK4 but not by cyclin E/CDK2 complexes and that p107 is able to bind the product of the c-Myc protooncogene and can block its activity as a transcriptional transactivator (Beijersbergen et al., 1994 (Beijersbergen et al., , 1995 Gu et al., 1994) . Viral oncoproteins as E1A of adenovirus, E7 of human papillomavirus and large T-antigen of SV40 are able to bind and inactivate Rb and possibly also to the related pocket proteins p107 and p130. As a consequence, transcription factors of the E2F/DP family are liberated from their constraints and are enabled to transactivate downstream target genes that initiate S-phase (for a review see Nevins, 1994) .
As key regulators of the G1 progression step within the cell cycle, D-and E-type cyclins have been suspected to play a pivotal role in the process of tumorigenesis. Most notably, cyclin D1 expression has been found to be disturbed in a number of human malignancies due to gene ampli®cation, chromosomal translocation or other mechanisms and its direct activity as an oncogene has been demonstrated in vitro and in vivo in a number of experimental systems (Hinds et al., 1994; Lovec et al., 1994a,b; Bodrug et al., 1994; Wang et al., 1994) . Cyclin E was also found overexpressed in human tumours but gene amplification as for cyclin D1 is rarely detected (Keyomarsi and Pardee, 1993; Leach et al., 1993; Gong et al., 1994; Keyomarsi et al., 1995) . Among human malignancies the strongest correlation was established between breast carcinoma and cyclin E overexpression; here the alterations of cyclin E expression have even been correlated with stage and grade of the disease (Keyomarsi et al., 1994) . First experiments with transgenic mice showed that constitutive expression of cyclin E can predispose for the development of mammary tumours after a long latency period (Bortner and Rosenberg, 1997) .
However, the mechanism underlying a potential oncogenic activity of cyclin E is not known and the regulation of cyclin E expression and activity in the process of malignant transformation has not yet been elucidated. In non-transformed cells expression of cyclin E appears to be positively regulated by mitogens and negatively by TGF-b. The promotor of the cyclin E gene has been isolated and analysed by several groups and was shown to contain multiple potential E2F binding sites. Transcriptional regulation indeed depends on the presence of these E2F binding sites and on the presence and function of Rb (Botz et al., 1996; Geng et al., 1996; Ohtani et al., 1995) . In addition to the regulation of cyclin E or cyclin D expression through the modulation of the promotor, the enzymatic activity of D-and E-type cyclin/CDK complexes is regulated independently on a posttranscriptional level. The transcription factor Myc, for example, which is a paradigmatic immediate early factor in response to mitogen stimulation with a clear involvement in G1 progression (for a review see Meichle et al., 1992) may be responsible for cyclin E/ CDK2 activation without changing the steady state level of the cyclin E or CDK2 protein itself (Steiner et al., 1995) . The cyclin dependent kinase inhibitors (CKIs) p27 and p21 both inhibit D-and E-type cyclin/CDK activity and at least D-type cyclin/CDK complexes seem to depend on the activity of Myc to exert their function in G1 progression or for their activity as oncoproteins (Roussel et al., 1995; Haas et al., 1997) . More recently, it was shown that overexpression of Myc but not cyclin D1 or cyclin E can overcome the p27 block in G1 (Vlach et al., 1996) also suggesting a regulatory function of Myc for G1 cyclin/ CDK complexes.
To investigate further the potential of cyclin E to malignantly transform cells and to address the question of the regulatory interdependency of D-and E-type cyclin/CDK complexes and the transcription factor Myc, we have used transfection experiments with primary rat ®broblasts as an experimental system. We show here that cyclin E very eciently transforms REF cells similar to cyclin D1 and Myc and that its oncogenic activity depends on functional Myc and an active cyclin D/CDK4 complex. Moreover, we show that constitutive expression of cyclin D1 and cyclin E correlates with lower sensitivity towards the induction of cell death and that particularly cyclin D1/Ha-ras transformed cells display a polyploid chromosomal status which points to a role of aberrant D-and possibly E-type cyclin expression in genomic instability.
Results
Cyclin E and Ha-ras oncogenically transform REFs that are tumorigenic in vivo Aberrant expression of cyclin E has been implicated in the aetiology of a number of human tumours (Keyomarsi and Pardee, 1993; Leach et al., 1993; Gong et al., 1994; Keyomarsi et al., 1995) which prompted us to test its oncogenic activity in a ®broblast transformation assay (Land et al., 1983; Lovec et al., 1994b) . We observed that transfection of primary rat embryo ®broblasts (REFs) with vectors expressing activated Ha-ras and cyclin E reproducibly leads to formation of foci of transformed cells demonstrating directly the oncogenic activity of cyclin E ( Table 1 ). The numbers of foci that were obtained per 1 million transfected REF cells in several independent experiments with cyclin E and Ha-ras ranged between 50 and 150 and thus were comparable to those reached in parallel experiments with Myc or SV40 large T-Ag and Ha-ras (Table 1) . Cyclin E/Ha-ras transformed cells established from foci were morphologically very similar to REFs transformed by a combination cyclin D1 and Ha-ras (Lovec et al., 1994b) or CDK4 (Haas et al., 1997) and activated Haras (not shown). Cyclin E/Ha-ras transformed cells expressed high levels of exogenous cyclin E protein compared to untransfected REF controls (Figure 1 ). They were also able to form colonies when seeded in soft agar at almost the same eciency as cells transformed by SV40 T-Ag/Ha-ras ( Figure 2 ) which was observed with two independent cell lines (CycE/1 and CycE/3) that had been derived from foci after transformation with cyclin E and Ha-ras. We next tested whether cyclin E/Ha-ras transformed cells were tumorigenic in vivo and injected three million cells from two dierent cyclin E/Ha-ras cell lines that had been established after REF transfection into both¯anks of three 10 day old syngeneic Fisher rats per cell line. The time in days was measured at which the emerging tumours had reached the size of about 1 cm in diameter. Cyclin E/Ha-ras cells (cell line CycE/1 and CycE/3) were comparable in their activity to form tumours with Myc/Ha-ras, SV40 large T-Ag/Ha-ras and cyclin D1/ Ha-ras transfected cells whereas CDK4/Ha-ras transformed cells (Haas et al., 1997) clearly had a lower malignant potential in this assay (Table 2) . Normal 
Given are the number of foci obtained after transfection of 10 6 primary REFs per assay with the indicated constructs together with activated Ha-ras. The vectors used for cyclin E, SV40 large T-Ag, Myc and Ha-ras have been described previously (Lovec et al., 1994b (Mumberg et al., 1996) . To investigate this in more detail in mammalian cells, we analysed the chromosome number of cells from dierent lines established from foci after transformation of REFs with either cyclin E, cyclin D1 or SV40 T-Ag in combination with activated Ha-ras. To this end, cells were treated with colcemid, washed from the plate and after ®xation and staining were analysed for chromosome numbers. For each cell line 100 mitotic ®gures were inspected and cells with chromosome number over 70 were counted as polyploid. We observed that cell lines established after transformation with cyclin D1 or cyclin E and Ha-ras contained between 26% and 94% tetraploid or near tetraploid cells (Table 3) whereas cells from lines established after SV40 large T-Ag/Ha-ras transformation contained only 3 ± 6% such polyploid cells (Table 3 ). Figure 3 shows a normal metaphase of a cyclin E/Ha-ras transformed cell with 42 chromosomes ( Figure 3a ) and a polyploid cell with 82 chromosomes (Figure 3b ) as well as a polyploid cell with 72 chromosomes (Figure 3c ). Two cyclin D/Ha-ras transformed cells with diploid and near tetraploid status are depicted in Figure 3d . As cell lines generated with SV40 large T-Ag and Ha-ras show a low proportion of polyploid cells (between 3 ± 6%, lines TA2 and TA3, Table 3 ) we concluded that the transformation process per se in our system was not responsible for this eect. To ensure that the observed eects are not a particular trait of a given established cell line we analysed another 12 independent lines established from foci after REF transfection with either SV40 large T-Ag and Ha-ras or Adenovirus E1A and Ha-ras by¯ow cytometry and did not observe polyploidy (not shown). Moreover, a more complete survey of cyclin D1/Ha-ras and cyclin E/Ha-ras lines showed that 15 of 18 cyclin D1/Ha-ras lines showed over 40% polyploid cells and three of 12 cyclin E/Haras lines. This suggests in agreement with previous observations in yeast (Mumberg et al., 1996) that aberrant expression of cyclin D-and to a lesser degree cyclin E correlates with aberrant chromosome numbers in oncogenically transformed cells and points to the possibility that G1 cyclins are involved in a cell cycle checkpoint that monitors ploidy.
Constitutive expression of cyclin E and activated Ha-ras renders cells less sensitive to apoptosis upon serum deprivation and DNA damage compared to other Ha-ras transformed cell lines
We next tested the serum dependency of cyclin E/Haras transformed cells in comparison to cells transformed by the combination of Myc/Ha-ras, cyclin D1/ Ha-ras or SV40 large T-Ag/Ha-ras. Cells that had been grown in medium with 10% FCS were washed and cultured in medium with 0.5% FCS for 2 days then refed with medium containing 0.5% FCS and cultured for another 2 days. After that period of 4 days serum starvation, cells were harvested (including dead¯oating cells), ®xed, stained with propidium iodide and analysed by¯uorescent activated cell sorting to detect
REFs
CycE/3 CycE/1 CycE/e Cyclin E Figure 1 Western blot analysis of exogenous cyclin E expression in three cell lines independently established from foci that arose after the transfection of cyclin E in combination with Ha-ras into primary REFs. The polyclonal anti cyclin E antiserum recognised two cyclin E proteins of 47 and 43 kD Figure 2 Anchorage independence of REF cell lines established from foci that arose after cotransfections with Myc and Ha-ras (line myc a), SV40 large T-Ag and Ha-ras (line TA2) and cyclin E and Ha-ras (lines CycE/1 and CycE/3). 10 4 cells of the indicated cell line were seeded in semisolid medium in two independent experiments (represented by the darker and lighter shading of the columns) and the emerging colonies were counted after 2 weeks (colony size40.05 mm) cells in the dierent cell cycle phases (G1/G0, S, G2/ M). Cells in apoptosis were measured by counting the percentage of cells that contain subG1 amounts of DNA (Rowan et al., 1996; Sofer-Levi and Resnitzki, 1996) . Because the nuclear fragmentation process associated with programmed cell death leads to lower incorporation of DNA dyes, the degree of PI incorporation can be used to account for cells in apoptosis (Darzynkiewicz et al., 1992) . We found that cell lines established after transformation with SV40 large T-Ag, Myc, cyclin D1, or cyclin E and Ha-ras have similar cell cycle characteristics evidenced for example by equivalent fraction of cells in S-phase before serum starvation (not shown). In contrast to cells transformed by the combination of SV40 large TAg, Myc or cyclin D1 and Ha-ras, cells established from cyclin E/Ha-ras foci were remarkably resistant towards the induction of cell death by serum starvation (Figure 4a) . Depending on the cell line, 2 ± 8% of cyclin E/Ha-ras transformed cells underwent apoptosis after serum withdrawal in contrast to 23 ± 55% in the other cell lines (Figure 4a ). It had been shown before that rat ®broblast cells transformed with activated Haras undergo apoptosis upon withdrawal of serum growth factors (Rowan et al., 1996) and the data obtained in our experiment suggest that a combination of cyclin E and Ha-ras is eective in rendering the cells less sensitive towards this death stimulus.
We next tested the eect of DNA damage on cyclin E/Ha-ras transformed cells and to quantify these eects we treated the same cell lines that were used before the serum starvation experiment now with etoposide which is an inhibitor of DNA topoisomerase II and induces DNA strand breaks. Cells were treated at a concentration of 0.2 mM etoposide for 24 h or left untreated. Subsequently, they were analysed by propidium iodide staining. Similar to the serum starvation experiment described above cells were analysed by¯uorescent cell sorting for their distribution within the dierent cell cycle phases (G1, S, and G2/M) or for the degree of cell death (subG1). We observed that induction of apoptosis by etoposide was ecient in the lines derived after transformation of REFs with SV40 T-Ag, Myc or cyclin D1 and Ha-ras. Between 10% and 20% of cells from these lines underwent cell death but only 4 ± 5% cells of the cyclin E/Ha-ras lines were in apoptosis (Figure 4b ). To con®rm this unexpected Tumorigenicity of cyclin E/Ha-ras transformed cells in synergeneic rats. Time in days is given at which the emerging tumour had reached the size of about 1 cm in diameter after injection of 3 million cells from the indicated cell lines. Cyclin E/Ha-ras cells were comparable in their activity to form tumours with Myc/Ha-ras, SV40 T-Ag/Ha-ras or cyclin D1/Ha-ras transfected cells. CDK4/Ha-ras cells (Haas et al., 1997) were considerably less eective in this assay. Histopathological analysis showed that all tumours were malignant ®brosarcomas (not shown) Percentage of polyploid cell in lines established after cotransfection expression vectors for Ha-ras and either cyclin D1, cyclin E or SV40 large T-antigen. For each cell line a population of 100 metaphases was counted and a polyploid status was accorded when over 70 chromosomes were counted correlation we established ®ve additional cyclin E/Haras cell lines and three additional Myc/Ha-ras cell lines from foci after REF transfection (all of diploid DNA content) and treated them with etoposide. All three Myc/Ha-ras lines showed high percentage (between 8 ± 29%) of apoptotic cells measured by PI uptake whereas none of the ®ve cyclin E/Ha-ras lines showed signi®cant degree of cell death (between 0.7 and 2%, Figure 4c ). This clearly suggests that the combinatorial expression of cyclin E and Ha-ras in ®broblasts and the concomitant malignant transformation provides protection against programmed cell death not only upon deprivation of serum growth factors but speci®cally apoptosis induced after DNA damage.
Oncogenic activity of cyclin E depends on CDK activity and Myc
The cyclin dependent kinase inhibitors (CKIs) p16, p21 and p27 have been shown to interfere with proper cell proliferation, in particular, p16 has been shown to block Myc/Ha-ras and CDK4/Ha-ras mediated transformation and Ha-ras induced cell proliferation (Serrano et al., 1995; Haas et al., 1997) . It is conceivable that the activation of the late G1 regulator cyclin E could potentially lead to independence from a block imposed by CKIs. To investigate the ability of the cyclin E/Ha-ras combination to override the G1 checkpoint controls that are governed by CKIs we transfected expression constructs of p16, p21, p27 and of a non-functional mutant of p16 (p16*) that had been isolated from human tumour cells along with vectors driving the expression of cyclin E and activated Ha-ras into primary REFs and scored the number of emerging foci. It had previously been shown that the expression of p16, p16* and p21 is not per se toxic to cells and that in the presence of SV 40 large T-Ag or E1A these CKIs do not interfere with cell proliferation and malignant transformation (Serrano et al., 1995; Haas et al., 1997) . Thus, REF transfections were performed with cyclin E and Ha-ras and either p21, p16, p16* or p27 expression constructs. Clearly, cyclin E/Ha-ras mediated transformation was eciently inhibited by the coexpression of either p16 and p21 or p27 ( Figure  5a ) but not by the tumour derived p16 mutant (p16*) (Figure 5a ) that contains a point mutation in a region that mediates binding to CDK4 demonstrating the dependency of cyclin E/Ha-ras transformation on functional cyclin/CDK complexes and with regard to the speci®city of p16 in particular the dependency of cyclin E on active CDK4.
A dependency of Myc/Ha-ras transformation on the activity of G1 cyclin/CDK complexes had been previously shown (Serrano et al., 1995; Haas et al., 1997) and vice versa, a requirement of Myc for the oncogenic activity of cyclin D1 or CDK4 has been reported (Haas et al., 1997 ). Therefore, we tested if the malignant transformation of primary REF cells by cyclin E also requires Myc. To this end, we used again the REF transformation assay as a test and performed cotransfection experiments using the Myc antagonist Mad as well as a dominant negative Myc (Myc-DN) mutant and as a control a non-functional Myc mutant (Myc DLZ). The dominant negative Myc mutant (Myc-DN) contained a deletion in the aminoterminal transactivation domain (aa position 104 ± 126) but retained its capacity to heterodimerize with Max and to bind DNA (Desbarats et al., 1996) . It has been shown that this mutant can eciently interfere with the activity of Myc as a transcriptional transactivator (Desbarats et al., 1996) . The non-functional Myc mutant (Myc DLZ) lacks the leucine zipper and is unable to engage in a DNA binding complex with Max (Desbarats et al., 1996) . The functionality of the expression constructs for Mad, Myc DN and Myc DLZ and also that Mad and the Myc DN mutant but not the non-functional Myc DLZ mutant interferred eciently with Myc/Ha-ras focus formation Figure 4 Analysis of cells cotransformed with a combination of either cyclin E (lines CycE/e and CycE/3 or lines CycE/4 to CycE/ 8), SV40 large T-Ag (lines TA2 and TA3), cyclin D1 (line CycD1/a) or Myc and Ha-ras (line myc a and lines myc 1 to myc 3). Cells were established as lines from foci and kept in medium with 10% serum (FCS). For the starvation experiment cells were washed and kept for 2 days in medium with 0.5% serum refed with medium (0.5% serum) and cultured for another 2 days. Cells growing in full serum and in low serum for 4 days were trypsinized, ®xed with ethanol and stained with propidium iodide (PI) and analysed. The number of dead cells (a) is plotted against the cell line tested. To analyse the eect of DNA damage on these cell lines they were incubated in etoposide for 24 h or left untreated as a control. The number of cells in apoptosis (b and c) was measured as above by PI incorporation and FACS analysis had previously been shown (Desbarats et al., 1996; Haas et al., 1997) . These expression vectors for Mad and both Myc mutants were used with cyclin E in a REF transfection assay together with expression construct for Ha-ras. Using focus formation as readout, we observed that the oncogenic activity of cyclin E is blocked by coexpression of the Myc antagonist Mad or by coexpression of a Myc dominant negative mutant but not by a nonfunctional Myc mutant that lacks the leucine zipper (Figure 5b ). These experiments indicated that malignant transformation by cyclin E still depends on a functional Myc protein and suggest a close interdependency between G1 speci®c cyclin CDK complexes and Myc.
Discussion
The oncogenic activity of D-type cyclins had been well established through a number of independent experimental strategies (Bodrug et al., 1994; Lovec et al., 1994a,b; Wang et al., 1994; Hinds et al., 1994; Kerkho and Zi, 1995) but a similar activity of other G1 cyclins has not been directly demonstrated. We show here that cyclin E which is another G1 speci®c cell cycle regulator but functions more close to the G1/S border than D-type cyclins and CDK4 is also capable to transform primary REFs in concert with activated Ha-ras. Cyclin E/Ha-ras transformed cells ful®l the classical criteria for malignant cells as they are able to grow and form colonies independent of a solid support and give rise to malignant tumours in syngeneic animals. This oncogenic activity of cyclin E is most interesting in the light of recent reports that implicate the deregulation of cyclin E in human cancer particularly breast carcinoma (Keyomarsi et al., 1995; Kitahara et al., 1995) and strongly suggest a direct role of aberrant cyclin E expression in the formation of a number of human malignancies that bear ampli®ed cyclin E genes. With this activity of cyclin E and recent ®ndings that ascribe a similar oncogenic potential to CDK4 (Haas et al., 1997) and CDC25 (Galaktionov et al., 1995) as well as the similar already known activity of D-type cyclins strongly suggest that all genes encoding positive G1 cell cycle regulators are in general protooncogenes and that their deregulated expression leads to a loss of growth control that is incremental in the process of malignant transformation. Moreover, this ®nding strengthens the relevance of restriction point control within the G1 phase of the cell cycle with regard to carcinogenesis (Bartek et al., 1996) . According to this hypothesis, all components involved in restriction point control are targeted in oncogenesis. The positive controllers (cyclins and CDKs) as oncoproteins as well as the negative controllers (the CKIs p16, p21 and p27) as potential tumour suppressor proteins (Bartek et al., 1996) . Figure 5 (a) Cyclin E/Ha-ras transformation is eciently inhibited by the CKIs p21, p16 and p27 but not by a tumour derived mutated of p16 (p16*, Lukas et al., 1996) . Given is the average number of foci with standard deviation obtained after three to four independent transfection assays with Ha-ras, Cyclin E and expression vectors for the indicated CKIs. The vector used to direct expression of the dierent CKIs did not in¯uence focus formation (not shown). The functionality of the expression constructs for the CKIs has been demonstrated previously (Haas et al., 1997) . (b) Transformation of REFs by cotransfection of cyclin E and Haras expression constructs is inhibited by cotransfection of the Myc antagonist Mad and of a Myc dominant negative mutant (Myc-DN) that lacks amino acids 104 ± 126 within the transactivation domain. As a control, the non-functional mutant of Myc (Myc DLZ) did not block focus formation. This mutant lacks the leucine zipper sequences and does not yield foci together with activated Ha-ras (data not shown). Given are the number of foci that are obtained against the cotransfected construct. The data show average numbers of foci including standard deviations from 3 ± 5 independent experiments. The vector used to direct expression of the dierent CKIs did not in¯uence focus formation (not shown). The functionality of the constructs used to direct expression of Mad and the Myc mutants has been shown previously (Haas et al., 1997) In contrast to REF cells transformed with viral oncoproteins and activated Ha-ras, transformation by D-and E-type cyclins leads to cell lines with a high percentage of tetraploid or near tetraploid cells. Polyploidisation is not uncommon in malignant cells but is also found in normal cells as for example in megakaryocytes where it correlates with the regulation of cyclin B1 and cyclin D3 expression (Datta et al., 1996; Zhang et al., 1996; Wang et al., 1995) . Polyploidisation can result from either endoreduplication or endomitosis. Endoreduplication involves a process that allows Sphase progression to take place without mitosis. In this case, metaphase arrested cells show ordered chromatid pairs because of the absence of cytokinesis. Clearly, this situation is not found in cyclin D/Ha-ras or cyclin E/Haras transformed cells suggesting that the polyploidisation here is the result of endomitosis rather than endoreduplication. Endomitosis allows cells to undergo all steps of a normal mitosis except cytokinesis and, consequently, cells are generated with polyploid nuclei very similar to the tetraploid cells found after cyclin E/ Ha-ras or cyclin D1/Ha-ras transformation pointing to a role of D-or E-type cyclins in a mitotic checkpoint. However, both cyclins have established functions in G1 progression and moreover are both predominantly expressed in G1 making an involvement of D-and Etype cyclins in the regulation of mitotic events rather improbable. It appears more likely that polyploid cells that are also generated under normal conditions as well as diploid cells leave mitosis at a similar rate but that polyploid cells arrest or die early in G1 at a checkpoint that monitors ploidy. It is possible that polyploid cells with high level of D-or E-type cyclin expression escape this checkpoint and rapidly progress into the next Sphase and subsequently emerge as cells with double chromosome numbers. However, cells with more than tetraploid chromosome numbers are probably eliminated by this checkpoint as they were very rarely observed in the Ha-ras transformed cells analysed here (51%, not shown).
The exact biochemical mechanism through which aberrant G1 cyclin expression leads to the transformation of cells still remains speculative. One possibility is that overexpression of D-or E-type cyclins leads to a higher associated kinase activity simply because more cyclin/CDK complexes are formed. However, higher cyclin/CDK kinase activity is not necessarily linked to higher amounts of the individual partner proteins because it depends on the activity of CAKs (CDK activating kinases) and the degree of phosphorylation (for a review see Draetta, 1997) and, in addition, cyclin/ CDK kinase complexes can be activated by releasing them from inactive high molecular weight complexes with inhibitors by still poorly de®ned biochemical steps (Steiner et al., 1995; Vlach et al., 1996) . Thus, higher levels of a particular cyclin would not necessarily lead to the formation of more cyclin/CDK dimers with kinase activity. It is therefore not unlikely that high levels of cyclin D or E contribute to malignant transformation because they bind to CKIs as p27 or p21, titrate these inhibitors away from the cyclin/CDK complexes and ensure a high level of endogenous cyclin/CDK kinase activity. As a consequence cell cycle progression is accelerated and uncoupled from restriction point control. The inhibition of focus formation by cotransfection of expression vectors for p21 and p27 in REF assays
as shown here supports this hypothesis. Both p21 and p27 have been recently shown to eciently bind to cyclins alone but not to associate with CDKs unless a cyclin is present (Hall et al., 1995) . Moreover, the biological eects of high level cyclin E expression may not only be related to cell proliferation and a faster progression into the S-phase but to inhibition of apoptosis. Recent experimental data using ®broblast cell lines with inducible cyclin E expression showed a protective eect of cyclin E expression after serum deprivation (Sofer-Levi and Resnitzki, 1996) . This is in agreement with data presented here that demonstrate that cyclin E/Ha-ras transformed cells are protected to a certain degree from apoptosis induced by serum deprivation or DNA damage. By contrast, cells transformed by Myc and Ha-ras or SV40 T-Ag and Ha-ras show a high degree of cell death after these stimuli. While the exact dissection of this function of cyclin E requires further experimentation, an inhibitory eect of cyclin E on programmed cell death would be fully compatible with its oncogenic activity. Moreover, an antiapoptotic activity of cyclin E might be relevant for the choice of treatment of human malignancies with ampli®ed or high level of cyclin E.
Coexpression of the CDK inhibitors p21, p27 and p16 that all block the activity of endogenous cyclin/CDK complexes very eciently interferes with the transforming activity of cyclin E. The speci®city of p16 for cyclin D/CDK4 complexes implicates that the oncogenic activity of cyclin E and other positive G1 regulators strictly depends on a functional D-type cyclin/CDK4 kinase. The eect of the CKIs used here more generally shows that malignant transformation of REFs per se requires G1-cyclin/CDK activity unless Rb or related pocket proteins are deleted as REF transformation with SV40 T-Ag or E1A and Ha-ras is not aected by CKIs (Serrano et al., 1995; Haas et al., 1997) . It has been previously proposed that one signalling pathway of cyclin D/CDK4 functions via the phosphorylation of the Rb related pocket protein p107 and the release of the Myc/Max transcription factor (Beijersbergen et al., 1994 (Beijersbergen et al., , 1995 Gu et al., 1994) . Taking into account recent ®ndings about the activation of the cyclin E/ CDK2 kinase by the induction of Myc through conditional alleles (Steiner et al., 1995) we had postulated that Myc acts downstream of cyclin D/ CDK4 and is regulated via the Rb related pocket protein p107 that is in turn uncontrolled by cyclin D/CDK4 activity and p16 (Haas et al., 1997) . In this model, Myc was placed upstream of cyclin E/CDK2 (Steiner et al., 1995) and downstream of cyclin D/CDK4 (Haas et al., 1997) . This model would also provide an explanation for the requirement of CDK4 kinase activity for the oncogenic activity of cyclin E. While it is possible that high level expression of cyclin E titrates enough p27 away to activate endogenous cyclin E/CDK2 kinase activity, a block of CDK4 by p16 for instance would lead to sequestration and inhibition of Myc/Max through underphosphorylated p107 (Beijersbergen et al., 1994 (Beijersbergen et al., , 1995 . As a consequence, cyclin E/CDK2 kinase activity that requires the function of Myc (Steiner et al., 1995, data shown here) would be inhibited and G1 progression and transformation is blocked. Further support for this model is provided by our ®nding that focus formation by cyclin E and Ha-ras is almost completely abrogated in the presence of Myc antagonists indicating that the transforming ability of cyclin E requires functionally active Myc. Although other possibilities cannot be excluded, this requirement is in agreement with data from Steiner et al. (1995) and would be fully compatible with a model that places cyclin D/CDK4 complexes upstream of Myc as an activator and the cyclin E/CDK2 complexes downstream of Myc as an eector.
Materials and methods

DNA constructs
The coding sequences of cyclin E and p21 were in the modi®ed pLTR vector (Lovec et al., 1994b) . Coding sequences of Myc, the Myc DN mutant and the Myc DLZ mutant and Mad had been cloned in a vector that directs ecient expression by SV40 promotor/enhancer elements. Expression of p16, p16* and p27 was driven through an CMV containing expression vector (pX). cDNAs for both p16 and p21 were generously provided by D Beach, the p16* clone was a gift from J Bartek. The sequence for SV40 large T-Antigen was expressed using the pMSE vector (Lovec et al., 1994b) .
Rat embryo ®broblast transformation assay and anchorage independence
Pregnant Fisher rats were killed at day 14, the embryos were removed and placed in sterile PBS. Cells from the carcasses were dispersed using trypsin/EDTA/1% chicken serum. The cells were separated from debris by low speed centrifugation, resuspended in DMEM/10% fetal calf serum (FCS) and plated at 1 million cells per 80 cm 2 dish. After the cells had reached con¯uency, they were replated at a density of 1 million per dish and used for transfections the following day. Transfections were carried out by the conventional calcium phosphate precipitation method overnight with 20 mg of DNA per dish. This included 10 mg of pEJ6.6 (Land et al., 1983) (containing the activated Ha-ras gene from a human bladder carcinoma) and 10 mg of the respective partner construct. Twenty-four hours after transfection the cells were washed and refed with medium. They were split another 24 h later into four plates and assayed for focus formation. The test for anchorage independence was done by plating 10 4 or 10 5 REFs, or the same number of cells from Myc/Ha-ras, SV40 T-Ag/Ha-ras and cyclin E/Ha-ras transformed lines established from foci in 0.33% agar on 28 cm 2 dishes on a 0.5% agar bottom. Colonies were scored after 2 weeks.
Analysis of cell cycle parameters and cell death
To analyse distribution in the dierent phases of the cell cycle and account for cells in apoptosis, foci derived after transfection of REFs were picked and established as cell lines as described (Lovec et al., 1994b) . These cell lines were grown in normal medium with 10% serum or were starved in 0.5% serum for up to 4 days. Cells were trypsinized, washed once with cold PBS and ®xed with ethanol overnight at 48C. The cells were again washed and then incubated in PBS, RNAse (40 mg/ml) and, 2 mg/ml propidium iodide (Sigma) for 30 min. FACS analysis was done in a FACSCALIBUR (Becton Dickinson).
Immunoblotting
Cells from REF lines were harvested in 1 ml PBS, collected by centrifugation, and lysed in 100 ml extraction buer (50 mM HEPES pH 7.8, 20 mM NaF, 1 mM Na-OrthoVanadat, 1 mM Na-Molybdat, 450 mM NaCl, 0.2 mM EDTA, 25% glycerol, 50 mg/ml aprotinin, 50 mg\ml leupeptin, 0.5 mM PMSF, 1 mM DTT, 1% NP-40). The lysate was cleared by centrifugation and the supernatant was separated by electrophoresis and transferred onto a nitrocellulose membrane. Untransfected cells were run as a control. The membrane was blocked over night in PBS/ 0.1% Tween 20 with 3% skim milk and then incubated in blocking solution containing the respective antibodies for 2 h at 0.3 mg/ml. Blots were developed with appropriate second antibodies and ECL detection reagents (Amersham) as proposed by the manufacturer. Anti-Cyclin antibodies stemmed from anity-puri®ed rabbit serum (Santa Cruz) and were used according to the instructions of the supplier.
Chromosome analysis
Cells were treated with 0.08 mg/ml Colcemid for 2 ± 4 h, washed from the petri dish and then pelleted by centrifugation. The cell sediments were treated for 10 min with 75 mM KCl in water, ®xed in methanol/acetic acid (3 : 1). Cells were then washed several times, resuspended in ®xative, dropped on glass slides, air dried stained with 5% Giemsa. Cells with a chromosome number of over 70 were counted as polyploid.
